2Mora C, Navarro JF. The role of inflammation as a pathogenic factor in the development of renal disease in diabetics E J 1- Curt Diab Rep, 2005,5(6) :399-401.
4Wolf G. Cell cycle regulation in diabetic neph ropathy. Kidney Int, 2000,58 ( Supp 177 ) :59-66.
5Volpini RA, Da Silva CG, Costa RS, et al. Effect of enalapril and losartan on the events that precede diabetic nephropathy in rots. Diabetes Metab Res Rev, 2003,19 ( 1 ) :43-51.
6Wolf G, N eilson EG. A ngiotensin as a renal growth factor. J Am Soc Nephrol, 1993,3 : 1531-1540.
7Nieslsen S, Schmitz A, Rehling M,et al. Systolic bllod pressure relates to the rate f deline of glomerular filtration rate in type II diabetes millitus. Diabetologia 1993 ; 16 : 1472.
8Mezzano S, Droguett A, Burgos ME, et al. Renin - angiotensin system activation and interstitial inflammation in human diabetec ne- phropathy. Kidney Int Suppl 2003 ;86:64 - 70.
9Can Z, Cox A, Bonnet F. Increased soteopontin expression following renal ablation is attenuated by angiotensin type I reception antagomism. Exn Neohrol 2002:10,19 - 25.
